Realm Therapeutics (RLM)

Sector:

Health Care

   Trade now with Barclays Stockbrokers   Trade now with Barclays   Sponsored by Barclays Stockbrokers

 7.38p
   
  • Change Today:
      0.000p
  • 52 Week High: 48.00p
  • 52 Week Low: 5.80p
  • Currency: UK Pounds
  • Shares Issued: 116.56m
  • Volume: 133,511
  • Market Cap: £8.60m

RLM Overview

Realm Therapeutics is an emerging specialty biopharmaceutical company focused on developing novel immunomodulatory therapies to protect and improve the lives of adults and children. The Company has initiated drug development programmes, based on its proprietary hypochlorous acid technology at high concentrations. The Company believes their formulations have novel immunomodulatory activity with potential application for the treatment of diseases in a number of therapeutic areas including Dermatology and Ophthalmology.

Key Personnel

CEO and Executive director: Alex Martin
CFO and COO: Marella Thorell
Chief Medical Officer: Christian Peters
Non-Executive Chairman: Charles Spicer
Senior Independent Non-Executive Director: Joseph William Birkett
Non-Executive Dir: Sanford Zweifach, Balkrishan (Simba) Gill, Ivan Gergel

Contact Details

Address: Cannon Place, 78 Cannon Street, London, EC4N 6AF
Phone: +44 (0) 20 7509 9900
Fax: +44 (0) 20 7509 9600
Website: www.realmtx.com

Listings

Sector: Health Care(LSE)
ISIN: GB00B3XBCR18

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

RLM Market Data

Currency UK Pounds
Share Price 7.38p
Change Today 0.000p
% Change 0.00 %
52 Week High 48.00p
52 Week Low 5.80p
Volume 133,511
Shares Issued 116.56m
Market Cap £8.60m

RLM Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
65.49% above the market average65.49% above the market average65.49% above the market average65.49% above the market average65.49% above the market average
69.70% above the sector average69.70% above the sector average69.70% above the sector average69.70% above the sector average69.70% above the sector average
Price Trend
96.08% below the market average96.08% below the market average96.08% below the market average96.08% below the market average96.08% below the market average
94.74% below the sector average94.74% below the sector average94.74% below the sector average94.74% below the sector average94.74% below the sector average
Income Not Available
Growth
25.02% below the market average25.02% below the market average25.02% below the market average25.02% below the market average25.02% below the market average
41.18% below the sector average41.18% below the sector average41.18% below the sector average41.18% below the sector average41.18% below the sector average

RLM Dividends

No dividends found

Trades for 18-Jan-2019

Time Volume / Share Price
15:26 133,511 @ 7.49p

Top of Page